The next issue will be published on May 28, 2021.   A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation í¬ published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciencesí¬is a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.
On the cover: Human civilization has been boosted by the development of chemistry, from fire-using to artificial fuels and chemicals. The advancement of chemistry brings us closer than ever to the nature of microscopic universe. Now, chemists are playing a critical role to develop green energy and intelligent materials. For a bright future of humanity, more and more breakthroughs in chemical technology are needed.
  Related comments
Add comment (English only)
Name*:  
E-mail:  
Telephone:  
Code:    
Comments*:
Position: Home > issue > February 28, 2021 Volume 2, Issue 1
Tackling COVID-19 in Africa: A Focus on Nigeria's Peculiarities and Challenges
Category: Commentary
Author: Oritoke Modupe Aluko, Saheed Adesile Lawal, Martin-Mary Falana, Ayotunde Samuel Adeagbo, Omamuyovwi Meashack Ijomone

222.png

Summary of COVID-19 Cases in Africa


Coronavirus disease (COVID-19) is an infectious disease caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first reported outbreak of COVID-19 was in China in December 2019. The World Health Organization (WHO) declared the outbreak a Public Health Emergency of International concern in January 2020 and a pandemic in March 2020. Italy confirmed its first cases in January 2020, and Nigeria in February 2020. By July 2020, more than 15.3 million COVID-19 cases were reported in more than 188 countries, resulting in over 630,000 deaths; although more than 9.3 million people recovered.


The novel SARS-CoV-2 primarily targets the respiratory system, resulting in severe acute respiratory symptoms as its hallmark. It is primarily transmitted from symptomatic people to individuals in close contact through respiratory droplets, or direct contact with contaminated objects/surfaces. There are mild to moderate respiratory symptoms in most COVID-19-infected people who recover without the need for special therapy. However, several other cohorts, particularly older people and those with underlying medical challenges, are more likely to develop serious illness. Treatments, such as dexamethasone, chloroquine/hydroxychloroquine, remdesivir, and convalescent plasma, have been deployed, although with controversial outcomes.





Host:   Academic co-partner: Stay connected:
    SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS

  inquiry@the-innovation.org
  the.innovation.journal
  the.innovation.journal
  The_InnovationJ
  TheInnovation┤┤đ┬
  TheInnovation┤┤đ┬

Publishing partner:   INSTITUTE OF MICROBIOLOGY, CAS
  XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
  Copyright © 2019-2021 Youth Innovation All Rights Reserved